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Overview: Mycobacterial infections are
important in humans and animals. Cats can be
infected by several Mycobacterium species,
which may cause different syndromes, mainly
tuberculosis, atypical or non-tuberculous
mycobacteriosis and leprosy. In recent years,
awareness has increased about how to
recognise and confirm these infections. More
cases are diagnosed today, which probably
means that the disease has escaped detection 
in the past. 
Infection: Most cases in cats are cutaneous,
presenting as nodules in the skin and draining
tracts, ulceration and local lymphadenopathy;
however, systemic dissemination may also occur. 
Diagnosis: Definitive diagnosis is difficult when
the bacterium cannot be detected by histology
or culture. However, species confirmation is
essential for treatment and prognosis, so
material for culture and polymerase chain
reaction should be submitted in every suspected
case. 
Treatment: Treatment is challenging. A
combination of two or three antibiotics is
needed, and treatment must be continued for
some months, which makes owner compliance
especially difficult in cats. 
Zoonotic risk: There is a zoonotic risk
associated with some mycobacterial species.
Concerns should be communicated in every
case of an immunocompromised owner in
contact with an infected cat.
Bacterial properties
Mycobacteria are intracellular, acid-fast, slow-growing bacilliform 
bacteria, highly resistant to environmental conditions.1,2 Mycobacterial
taxonomy is complex and many species can infect the cat and induce 
a variety of clinical presentations. Different classifications have been
made in the past based on features and ability to grow in culture, 
as well as biochemical properties.2 The use of molecular techniques 
has led to taxonomic changes, and some species have been or will be
classified into different groups.2
For practical purposes, we here classify mycobacteria on the basis of
their biological behaviour, including aspects of clinical presentation, diag-
nosis and culture, their response to treatment and on zoonotic aspects.
Tuberculosis (TB) complex group
Mycobacterium tuberculosis (mainly infecting humans and dogs, rarely
cats and other species), M bovis (infecting cattle, dogs and cats) and 
M microti (infecting small rodents like voles, shrews and cats) are bac-
teria that can be grown only in specific culture media. Tuberculosis in
cats is a systemic disease with disseminated internal lesions,3,4 but cats
with M microti infection may also present with localised or disseminat-
ed cutaneous disease.5 
Non-tuberculous mycobacteria (NTM) group 
This group includes a large number of slow-growing species like 
M mageritense, M genavese and M malmoense and rapidly growing
species like M fortuitum, M chelonae-abscessus, M avium, M smegmatis, 
M flavescens and the M avium–intracellulare complex (MAC) among 
others. NTM infections in cats are typically subcutaneous (local or 
disseminated), rarely progressing to systemic disease.6 However, MAC
infections, which in some classifications are included within the TB
complex group, are frequently sytemic.3,7
Feline leprosy
The M lepraemurium and several other species cannot be grown in cul-
ture. Infection in cats is restricted to the skin where it produces mainly
localised and rarely disseminated cutaneous nodules.8
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Epidemiology 
The prevalence of mycobacterial infections in
cats is unknown. They are considered rare,
but case series or case reports from the United
States, Australia, New Zealand and several
European countries have been published. 
In recent years, more cases have been 
recognised, probably meaning that the infec-
tion was under-diagnosed previously.7,9,10 A
2009 survey from diagnostic laboratories in
the UK evaluating tissue samples with a histo-
logical diagnosis of mycobacterial infection
showed a significant incidence of around
1%.10
Data on the prevalence of the different
mycobacterial species are also lacking.
However, a recent retrospective study from
the UK evaluating 339 cases of mycobacterial
disease in cats found that 53% could not be
identified through culture, 19% were M
microti, 15% M bovis, 7% MAC and 6% of the
NTM group.5 Most cats with mycobacterial
infections have an outdoor lifestyle;5,8 living
in a non-urban area seems to increase the
risk.10 Adult tom cats seem to be predisposed
to developing disease,3,5 as are Siamese and
Abyssinian breeds.5,7,11 
TB complex group
M microti infection is mainly related to direct
contact with small rodents like voles and
mice.12
M tuberculosis infection is rare in cats, prob-
ably due to their natural resistance.13 M tuber-
culosis and M bovis are directly transmitted to
cats by ingestion of milk from infected cattle
and by direct or environmental contact with
badgers (M bovis).14
NTM group
The main risk to cats is wound
contamination by mycobacteria
present in the environment (soil,
water and decaying vegeta-
tion).6,9,15,16
Feline leprosy
The main risk comes from
direct contact or rodent bites,
or from wound contamina-
tion by mycobacteria present
in the soil or on plants.7,17
Figure 1 Mycobacterial
infection in the ventral
abdomen. Courtesy of 
Richard Malik, University of
Sydney Veterinary School
Pathogenesis
Mycobacteria infect the macrophage and
induce granulomatous and pyogranuloma-
tous inflammatory responses in the organs
involved.18 The mycobacterial species, route
of infection and immune responses determine
the extent, location and severity of the lesions. 
TB complex group
The primary site of infection by M tuberculosis
and M bovismay be the alimentary tract, lungs
or skin.2,15 From these sites dissemination and
systemic infection may occur. Occasionally,
the infection is primarily systemic. 
In M microti infection, the portal of entry is
the skin, in locations commonly affected by
wild rodent bites (the face and legs).5
NTM group
The primary site of








in lipid-rich tissues, like
the ven tral abdominal
and inguinal areas, par-
ticularly after a surgical wound contamination
(Figure 1). A lipoid pneumonia case caused by
mycobacterial infection has also been report-
ed.19 Dis semi nation from the skin and sys-
temic infections are not common for bacteria of
this group, with the exception of MAC infec-
tions, which are easily disseminated.6,11,20–22
Feline leprosy
The primary site of infection is the skin, with
localised subcutaneous granulomas and, less
commonly, disseminated skin granulomas.7
Clinical presentation 
Most mycobacterial infections occur in
immunocompetent animals.3,5 Cases in cats
with primary or acquired immunodeficiency
have been documented. Two
feline immuno deficiency virus-
positive cats with atypical
mycobacterial infection have
been reported.23,24 One case has
been documented of an atypical
mycobacterial infection in a cat
with an idiopathic CD4+ lym-
phopenia.25 Two cases (MAC dis-
seminated infection and
mycobacterial osteomyelitis) have
been reported after renal transplan-
Mycobacterial taxonomy is complex 
and many species can infect the cat and induce 
a variety of clinical presentations. 
European Advisory Board on Cat Diseases
The European Advisory Board on Cat Diseases (ABCD) is
a body of experts in immunology, vaccinology and clinical
feline medicine that issues guidelines on prevention and
management of feline infectious diseases in Europe, for the
benefit of the health and welfare of cats. The guidelines are
based on current scientific knowledge of the diseases and
available vaccines concerned.
The latest version of the mycobacterioses 
in cats guidelines is available at www.abcd-vets.org
REV IEW / ABCD guidelines on mycobacterioses
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tation and long-term immunosup-
pressive therapy with ciclosporin.26,27
Cutaneous forms
M microti, the NTM group and feline
leprosy species are the most common
mycobacteria producing skin lesions.
These typically consist of dermal
nodules, non-healing wounds with
draining tracts and ulceration
(Figures 2–4).4,5,8–10 Common loca-
tions are the facial area, extremities,
tail base, perineum, ventral thorax
and abdomen. Lesions may be soli-
tary or multiple.5,9 Multiple skin
lesions may result from local spread or
haematogenous dissemination. Local or gen-
eralised lymphadenopathy is present
in about half of the cases and may be
the only clinical sign (especially sub-
mandibular and prescapular).5
Visceral (digestive or respiratory)
or systemic forms
The TB complex and MAC species
are the most common mycobacteria
producing visceral or systemic
lesions.3,20–22 NTM infections rarely
produce disseminated disease.19
Common clinical signs and abnor-
malities are digestive (weight loss,
mesenteric lymphadenopathy) or res-
piratory (pneumonia, hilar lym-
phadenopathy, pneumothorax, pleural or
perdicardial effusions), and may be accom -
panied by signs of systemic dissemination 
like fever, ocular signs, splenomegaly,
hepatomegaly, generalised lymph adenopathy,
bone lesions and central nervous system
signs.3,6,11,20–22,27 
Diagnosis 
Diagnosis may be difficult, especially when
skin lesions are absent. It is based on a clinical
suspicion when the presentation is indicative
and other diseases are ruled out. In
these cases, appropriate samples
should be obtained for cytology
and/or histology (including acid-fast
staining), culture and polymerase
chain reaction (PCR).
Haematology and biochemistry
changes are non-specific, suggesting
a chronic inflammatory condition.
Hypercalcaemia due to granulo -
matous disease has been reported in
systemic MAC6 and M microti infec-
tions.4 Cats infected with mycobac -
teria may show reduced levels of
vitamin D when compared with
healthy cats, as occurs in humans.28
Thoracic radiographic changes are variable
and non-specific, ranging from no
abnormalities to bronchial, alveolar
or interstitial nodular mixed patterns,
pleural effusion and/or mediastinal
and perihilar lymphadenopathy
(Figure 5).29 Appendicular radio -
graphs may show bone osteolytic
lesions, and less frequently osteopro-
liferative changes, associated with
systemic infections.27,29 Abdominal
ultrasound may be useful for 
iden tifying mesenteric lymphadeno -
pathy or granulomatous lesions 
and as a guide to obtain fine needle
aspirates.26
Cytology
Fine needle aspirates or smears from skin
lesions (nodules, ulcers, draining tracts) or
from granulomatous lymph nodes should
always be stained for acid-fast bacteria using,
for example, the Ziehl-Neelsen (ZN) proce-
dure. Sensitivity is variable, as the number of
bacteria within macrophages varies depend-
ing on the mycobacterial species and on the
host’s immune response.2 A negative cytology
result does not rule out mycobacterial infec-
tion [EBM grade III].10 If cytology suggests a
granulo matous inflammation, a biopsy for 
Figure 2 Ulcerated skin
nodule in M microti infection.
Courtesy of Richard Malik,
University of Sydney Veterinary
School
Figure 3 Subcutaneous skin
nodule in NTM infection.





Subcutaneous nodules in a
cat with leprosy. Courtesy of





for grading the level
of evidence of
various statements
within this article is
described on 
page 533 of this
Special Issue.
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histology must be obtained. Samples for 
culture and PCR should be obtained in all
cases when a mycobacterial infection is 
suspected (granulomatous inflammation and
ZN-positive staining).
Histology
Histology is useful in the diagnosis of
mycobacterial infections. It allows the inflam-
matory pattern (pyogranulomatous or granu-
lomatous) to be assessed and special acid-fast
staining, like ZN, to be performed (Figure
6).18,30 However, only a few bacteria may be
present and pass undetected by staining 
(M microti and some NTM species), although
culture or PCR may give a positive result
[EBM grade III].10,30 Bacterial morphology and 
staining do not allow identification of the
mycobacterial species. If a mycobacterial
infection is suspected it is mandatory to keep
fresh biopsy samples frozen for further cul-
ture and PCR.2
Culture
Culture from a fresh tissue sample is useful to
confirm mycobacterial infection and to identi-
fy the species involved, which has implica-
tions for treatment, prognosis and assessment
of zoonotic risk. This needs to be done in a spe-
cialised laboratory and, even still, many
mycobacterial species are slow growing (2 to 3
months) or fail to grow [EBM grade III].5,10 In
feline leprosy and some forms of NTM infec-
tion, cultures are always negative, even when
ZN staining has been positive [EBM grade
III].7,17,30 Due to these limitations it is advisable
to simultaneously submit samples for PCR.
PCR
PCR (eventually followed by sequencing) is the
recommended test for diagnosing mycobac -
terial infections [EBM grade III].4,13,18 It allows
confirmation of the diagnosis and species iden-
tification more rapidly than any other proce-
dure. Availability may be limited depending on
the private diagnostic laboratories in the area.
Samples should alternatively be submitted to
an official national laboratory for mycobacteri-
al diagnosis.
Interferon gamma test and other
immunoassays 
These tests are currently commercially
unavailable, but they are promising for the
diagnosis of TB complex group infections.31,32
A recent study evaluating a cell-based inter-
feron gamma test and serum antibody tests
showed excellent specificity and a variable,
moderate sensitivity [EBM grade II].33 
Figure 5 Mixed
bronchial–interstitial pattern
in the lungs of a cat with TB
complex group infection.
Courtesy of Richard Malik,
University of Sydney Veterinary
School
Figure 6 Large numbers of
acid-fast bacteria revealed
using the Ziehl–Neelsen
stain. Courtesy of Richard
Malik, University of Sydney
Veterinary School
If a mycobacterial infection is suspected 
it is mandatory to keep fresh biopsy samples frozen
for further culture and PCR.
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Treatment 
Treatment of mycobacterial infections is 
generally difficult and challenging. There are
no prospective controlled clinical trials, and
recommendations are based on case reports or
retrospective studies. Good outcomes have
been published after identification of the
mycobacterial species and treatment with a
long (several months) course of an appropri-
ate antibiotic combination [EBM grade III].2,30
Surgery is indicated when local skin lesions
can be removed; more diffuse lesions can be
treated with surgical debridement and the cat
subsequently treated with appropriate anti -
biotics [EBM grade III].8,34
Some important considerations before
embarking on treatment are outlined in the
box above. 
TB complex group and NTM group
Currently, double or triple therapy is recom-
mended: rifampicin (10–15 mg/kg q24h) plus
a quinolone (marbofloxacin 2 mg/kg q24h)
plus a macrolide (clarithromycin 125 mg/cat
q24h or azithromycin 5–15 mg/kg q24h) for
6–9 months. Ideally, the three drugs should be
giving during an initial phase of 2 months, 
followed by two of the drugs for 4–7 months
[EBM grade III].2,3 In many cats, an
oesophageal tube is needed to allow for such
long and intensive pill administration.2
Adverse effects (cutaneous, hepatic) are not
uncommon, and in some cats treatment must
be discontinued.2
Short courses of antibiotic and/or
monotherapy (eg, quinolones or beta-lactams)
have been associated with clinical responses
and remissions, but also with a high risk of
relapse, which may be followed by systemic
spread.30 It is recommended always to start
complete treatment while waiting for diag-
nostic confirmation and species identification.
MAC infections 
Disseminated MAC infections usually
respond poorly to treatment, and quinolones
are not very effective [EBM grade IV].20–22
Recommended first-line therapy is clari -
thromycin with clofazimine (4–8 mg/kg q24h)
or rifampicin or doxycycline (5–10 mg/kg
q12h) based on the few cases reported with
good outcomes [EBM grade IV].8,37,38
Feline leprosy 
Most cats with leprosy can be cured by surgery
(small lesions) and applying combinations of
rifampicin, clofazimine and clarithromycin 
for several months [EBM grade III].1,7 Spon -
taneous remission has been documented in
one cat [EBM grade IV].39
Prevention
Keeping cats indoors and avoiding contact
with wild rodents are the only measures for
preventing mycobacterial infection. 
Prognosis 
The prognosis generally must be considered
guarded, but depends on the mycobacterial
species and the extent and severity of the dis-
ease. Disseminated infections (TB complex and
MAC) are associated with a poor progno-
sis.3,9,20–22 Localised skin disease (NTM infec-
tion), M microti infection and leprosy may have
a good prognosis if treated appropriately.7,8,30
Po t en t i a l  zoono t i c  r i s k
All members of the TB complex group (including M microti) and
the MAC are potentially zoonotic. However, the risk of
transmission from cats (and dogs) to humans is low.2,14,35 There is
a single published report from Australia of a human mycobacterial
infection – a case of M marinum (NTM group) local skin infection
acquired from a cat after a scratch.40 Conversely, cats are at risk
of infection if the owner is diagnosed with tuberculosis. 
The use of gloves is strongly
recommended when treating cats
with suspected mycobacterial
infections and/or when taking and
processing biopsy samples. National
regulations need to be consulted to establish












All members of the TB
complex group (including 
M microti) and the MAC are
potentially zoonotic.
Important issues to consider before starting treatment
< The zoonotic risk (particularly of the TB complex group including M microti, and the MAC) must be discussed with the
owner;2,35 especially, but not exclusively, if the owner suffers from an immunodeficiency condition. In some cases we
should advise against treating these cats. 
< Confirmation (by culture or PCR) of the mycobacterial species may take time. In some instances, the zoonotic risk (in the
case of M tuberculosis or M bovis) may be unacceptable, and inappropriate initial antibiotic selection may lead to the
development of mycobacterial resistance.2,30,36
< Treatment requires several months of an antibiotic combination regimen; compliance, risk of adverse effects and financial
issues must be discussed with the owner. 
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